Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Vimentin ELISA Kit (AC3694)
Cat.#: ASET-2283
Specifications
Description Human Vimentin ELISA Kit allows for the in vitro quantitative determination of human Vimentin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.688 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 7.813-500 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2204 Mouse Netrin 1 ELISA Kit (AC3615) Quantitative inquiry ASET-2135 Human SNAP23 ELISA Kit (AC3546) Quantitative inquiry ASET-1413 Rat Ferritin Heavy Chain ELISA Kit (AC2824) Quantitative inquiry ASET-1303 Mouse Neurotrophin 3 ELISA Kit (AC2714) Quantitative inquiry ASET-1264 Rat TSH beta ELISA Kit (AC2675) Quantitative inquiry ASET-1024 Chicken FGF2 ELISA Kit (AC2435) Quantitative inquiry ASET-2114 Human SPON2 ELISA Kit (AC3525) Quantitative inquiry ASET-1583 Chicken Adiponectin ELISA Kit (AC2994) Quantitative inquiry ASET-2094 Mouse VMAT2 ELISA Kit (AC3505) Quantitative inquiry ASET-1951 Mouse Midkine ELISA Kit (AC3362) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket